In mouse models of stroke, administration of full-length OPN, thrombin-cleaved OPN and peptides based on sequences from the N-terminal and C-terminal sides of the thrombin cleavage site all protect against ischemic brain injury [6,7]. This evidence concerns the gene SPP1 and stroke disorder.